Avricore Health Inc.
corporate_fare Company Profile
Avricore Health Inc. (OTC:AVCRF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for AVCRF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-16, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for AVCRF spans 6-K.
Recent high-impact activity:
- Avricore Signs Multi-Year Abbott Deal for UK Point-of-Care Testing
- Avricore Health Closes Upsized $1.254M Private Placement with Insider Participation
- Avricore Health Secures $1.25M Private Placement to Address Going Concern
- Avricore Health Faces Going Concern Warning Amidst 89% Revenue Drop and Increased Losses
- Avricore Health's HealthTab™ Expands to 70 New Pharmacy Sites in North East London NHS Program
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for AVCRF, detected from its recent SEC filings · based on capital-structure filings through 2026-07-11.
Private Placement Closed · Insider Participation
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
AVCRF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.